Investigating the Use of Melatonin in Children With Atopic Dermatitis: A Cross‐Sectional Study
Pediatric Dermatology · 2025-11 · 42 (6) · 1156-1162
DOI: 10.1111/pde.70041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Dermatology, online erschienen am 09.09.2025. Verfasst von Sarah Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Melatonin, Dermatitis, Atopic, Sleep Wake Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background/Objectives Children with atopic dermatitis (AD) frequently experience sleep disturbances. Melatonin, an over‐the‐counter supplement, is increasingly used in the general pediatric population; however, its prevalence and perceived effectiveness in children with AD remain unclear.
Methods
Caregivers of pediatric patients (ages 1–17 years) with physician‐diagnosed AD completed surveys on melatonin use, Patient Oriented Eczema Measure (POEM), and age‐appropriate sleep questionnaires.
Results
Among 102 total respondents, 27.5% reported a history of melatonin use, with 10.8% using it in the past 30 days. Gummies were the most common formulation (85.7%), though brands and dosages varied widely (0.5–10 mg; median: 3 mg). 32.1% of caregivers initiated melatonin based on a healthcare professional's recommendations, while the majority initiated use independently (50.0%) or based on recommendations from friends/family (21.4%) or online resources (7.1%). Melatonin use was significantly more common among children with behavioral or psychological comorbidities compared to those without (56.3% vs. 22.1%; p = 0.012). Children ages 6‐17 who used melatonin had significantly higher PROMIS Sleep Disturbance scores than nonusers ( p < 0.001). Perceived effectiveness varied: for sleep, 21.4% of caregivers found melatonin very useful, 32.1% somewhat useful, and 39.3% of little or no use. For nocturnal itch, 14.3% found melatonin very useful, 17.9% somewhat useful, and 50.0% of little or no use.
Conclusions
There is a high prevalence of melatonin use among children with AD. Most caregivers are initiating melatonin independently, and dosage varies widely. Given mixed caregiver‐reported effectiveness of melatonin and limited long‐term safety data, it is imperative that further studies are performed to evaluate melatonin's role in children with AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Harvard Medical School, Boston, Massachusetts, USA.
- Division of Immunology, Boston Children's Hospital, Boston, Massachusetts, USA.
- Dermatology Section, Division of Immunology, Boston Children's Hospital, Boston, Massachusetts, USA.
- Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Sarah Lee, Eun Jae Kim, Tina Ho
Zitieren
APA
Lee, S., Kim, E. J., LeBovidge, J., Aigbekaen, I., Berbert, L., Schneider, L., & Ho, T. (2025). Investigating the Use of Melatonin in Children With Atopic Dermatitis: A Cross‐Sectional Study. Pediatric Dermatology, 42(6), 1156-1162. https://doi.org/10.1111/pde.70041
Vancouver
Lee S, Kim EJ, LeBovidge J, Aigbekaen I, Berbert L, Schneider L, et al. Investigating the Use of Melatonin in Children With Atopic Dermatitis: A Cross‐Sectional Study. Pediatric Dermatology. 2025;42(6):1156-1162. doi:10.1111/pde.70041
BibTeX
@article{Lee2025,
author = {Lee, Sarah and Kim, Eun Jae and LeBovidge, Jennifer and Aigbekaen, Itohan and Berbert, Laura and Schneider, Lynda and Ho, Tina},
title = {Investigating the Use of Melatonin in Children With Atopic Dermatitis: A Cross‐Sectional Study},
journal = {Pediatric Dermatology},
year = {2025},
volume = {42},
number = {6},
pages = {1156--1162},
doi = {10.1111/pde.70041}
}
EUVIMED